Gossamer Bio, Inc. Common Stock (GOSS) Stock Price

GOSSStock

$8.77−95.25%52W

Market Cap$53.64M

P/E—

PEG Ratio—

Div yield—

Beta2.29

GOSS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-84.53%

Price vs S&P 500 (4W)-20.93%

VGM Score49.80

Book Value / Share (Quarterly)$0.13

P/TBV (Annual)14.41x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.33

Price vs S&P 500 (YTD)-108.39%

Net Profit Margin (TTM)-235.00%

EPS (TTM)$-0.56

10-Day Avg Trading Volume0.27M

EPS Excl Extra (TTM)$-0.56

EPS (Annual)$-0.75

ROI (Annual)-24.90%

Cash / Share (Quarterly)$0.12

Revenue Growth QoQ (YoY)-19.59%

ROA (Last FY)-98.91%

Revenue Growth TTM (YoY)32.43%

EBITD / Share (TTM)$-0.48

ROE (5Y Avg)-528.46%

Operating Margin (TTM)-229.42%

Cash Flow / Share (Annual)$-0.73

P/B Ratio1.85x

P/B Ratio (Quarterly)7.07x

Net Income / Employee (Annual)$-1,058,200

EV / Revenue (TTM)0.91x

Net Interest Coverage (TTM)-17.90x

ROA (TTM)-85.35%

EPS Incl Extra (Annual)$-0.75

Current Ratio (Annual)2.64x

Quick Ratio (Quarterly)0.46x

3-Month Avg Trading Volume0.34M

52-Week Price Return-95.25%

Revenue / Employee (TTM)$331,000

Tangible BV / Share (Quarterly)$0.46

P/S Ratio (Annual)1.11x

Asset Turnover (Annual)0.28x

52-Week High$309.60

EPS Excl Extra (Annual)$-0.75

CapEx CAGR (5Y)-44.50%

26-Week Price Return-74.62%

Quick Ratio (Annual)2.35x

13-Week Price Return-35.56%

Total Debt / Equity (Annual)6.70x

Current Ratio (Quarterly)0.53x

Enterprise Value$48.59M

Asset Turnover (TTM)0.36x

Book Value / Share Growth (5Y)-53.08%

Revenue / Employee (Annual)$301,100

Pretax Margin (Annual)-351.67%

Cash / Share (Annual)$0.59

3-Month Return Std Dev136.57%

Net Income / Employee (TTM)$-777,800

ROE (Last FY)-191.67%

Net Interest Coverage (Annual)-19.13x

EPS Basic Excl Extra (Annual)$-0.75

Receivables Turnover (TTM)7.79x

Total Debt / Equity (Quarterly)6.83x

EPS Incl Extra (TTM)$-0.56

ROI (TTM)-23.00%

P/S Ratio (TTM)1.01x

Revenue / Share (Annual)$0.21

Tangible BV / Share (Annual)$0.13

Price vs S&P 500 (52W)-110.79%

Year-to-Date Return-96.46%

5-Day Price Return-5.50%

EPS Normalized (Annual)$-0.75

ROA (5Y Avg)-65.35%

Net Profit Margin (Annual)-351.49%

Month-to-Date Return-25.99%

Cash Flow / Share (TTM)$-1.55

EBITD / Share (Annual)$-0.75

Operating Margin (Annual)-352.23%

LT Debt / Equity (Annual)6.70x

ROI (5Y Avg)-63.48%

LT Debt / Equity (Quarterly)6.81x

EPS Basic Excl Extra (TTM)$-0.56

P/TBV (Quarterly)1.66x

P/B Ratio (Annual)6.95x

Pretax Margin (TTM)-235.17%

Book Value / Share (Annual)$0.13

Price vs S&P 500 (13W)-38.25%

Beta2.29x

P/FCF (Annual)2679.49x

Revenue / Share (TTM)$0.16

ROE (TTM)-118.77%

52-Week Low$8.51

vGradeB

gGradeC

mGradeD

vgmGradeC

GOSS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$9.99	-$8.17	+18.23%(+$1.82)
Q1 2026	May 15, 2026	-$13.64	-$16.00	-17.30%(-$2.36)
Q4 2025	Mar 17, 2026	-$15.65	-$16.80	-7.33%(-$1.15)
Q3 2025	Nov 5, 2025	-$15.77	-$16.80	-6.52%(-$1.03)
Q2 2025	Aug 5, 2025	-$0.18	-$0.17	+5.82%(+$0.01)

GOSS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.64

3.79

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
GOSSGossamer Bio, Inc. Common Stock	B	C	D	1.0x	32.4%	—	—	$8.77
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Gossamer Bio, Inc. Common Stock

Gossamer Bio is a clinical-stage biopharmaceutical company developing therapeutics in immunology, inflammation, and oncology. Its pipeline includes Seralutinib for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB1275 for oncology indications, and GB001 for eosinophilic asthma.